Geography may limit access to cancer clinical trials

December 3, 2014 9:29 PM

12 0

Fewer than 10 percent of U.S. cancer patients participate in clinical trials, the authors note.

“Clinical trials are the basis for the vast majority of advances in cancer care, so, the only way to move the field forward is for patients to participate in clinical trials,” said lead author Dr. Matthew D. Galsky of the Icahn School of Medicine at Mount Sinai in New York.

Read more

To category page